Literature DB >> 16033329

Vascular complications in diabetes mellitus: the role of endothelial dysfunction.

Casper G Schalkwijk1, Coen D A Stehouwer.   

Abstract

The endothelium is a complex organ with a multitude of properties essential for control of vascular functions. Dysfunction of the vascular endothelium is regarded as an important factor in the pathogenesis of diabetic micro- and macro-angiopathy. Endothelial dysfunction in Type I and II diabetes complicated by micro- or macro-albuminuria is generalized in that it affects many aspects of endothelial function and occurs not only in the kidney. The close linkage between microalbuminuria and endothelial dysfunction in diabetes is an attractive explanation for the fact that microalbuminuria is a risk marker for atherothrombosis. In Type I diabetes, endothelial dysfunction precedes and may cause diabetic microangiopathy, but it is not clear whether endothelial dysfunction is a feature of the diabetic state itself. In Type II diabetes, endothelial function is impaired from the onset of the disease and is strongly related to adverse outcomes. It is not clear whether impaired endothelial function is caused by hyperglycaemia or by other factors. Impaired endothelial function is closely associated with and may contribute to insulin resistance regardless of the presence of diabetes. Endothelial dysfunction in diabetes originates from three main sources. Hyperglycaemia and its immediate biochemical sequelae directly alter endothelial function or influence endothelial cell functioning indirectly by the synthesis of growth factors, cytokines and vasoactive agents in other cells. Finally, the components of the metabolic syndrome can impair endothelial function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033329     DOI: 10.1042/CS20050025

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  183 in total

1.  Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes.

Authors:  Y Chen; J J Wang; J Li; K I Hosoya; R Ratan; T Townes; S X Zhang
Journal:  Diabetologia       Date:  2012-06-04       Impact factor: 10.122

Review 2.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

Review 3.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

4.  Post-transcriptional down regulation of ICAM-1 in feto-placental endothelium in GDM.

Authors:  Francisca Isidora Díaz-Pérez; Ursula Hiden; Martin Gauster; Ingrid Lang; Viktoria Konya; Akos Heinemann; Jelena Lögl; Richard Saffery; Gernot Desoye; Silvija Cvitic
Journal:  Cell Adh Migr       Date:  2016-01-13       Impact factor: 3.405

5.  Evaluation of the Serum Levels of Nitric Oxide among Diabetic Patients and its Correlation with Lipid Profile as well as Oxidative Stress in North Indian Setting.

Authors:  Sanjeev Kumar; Arvind Trivedi; Neetu Verma; Ajay Panwar; Pradeep Kumar
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 6.  Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes.

Authors:  M J Sampson; D A Hughes
Journal:  Diabetologia       Date:  2006-06-21       Impact factor: 10.122

7.  Impairment of skin capillary recruitment precedes chronic complications in patients with type 1 diabetes.

Authors:  Eduardo Tibirica; Elba Rodrigues; Roberta Cobas; Marilia B Gomes
Journal:  Rev Diabet Stud       Date:  2007-08-10

Review 8.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease.

Authors:  C D A Stehouwer; R M A Henry; I Ferreira
Journal:  Diabetologia       Date:  2008-02-01       Impact factor: 10.122

9.  Cell matrix contact modifies endothelial major histocompatibility complex class II expression in high-glucose environment.

Authors:  Markus Nickmann; Michael Saemisch; Ute Wilbert-Lampen; Thomas Nickel; Elazer R Edelman; Heiko Methe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

10.  Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes.

Authors:  Cecilia Marini; GianPaolo Bezante; Patrizia Gandolfo; Elisa Modonesi; Silvia D Morbelli; Angelo Depascale; Daniela Rollando; Davide Maggi; Manuela Albertelli; Riccardo Armonino; Manrico Balbi; Claudio Brunelli; Renzo Cordera; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.